drugset / Trial / NCT01882491
Safety and Biologic Activity Study of Gevokizumab to Treat Erosive Osteoarthritis of the Hand
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this proof-of-concept study is to determine whether gevokizumab is effective in the treatment of inflammatory erosive osteoarthritis of the hand.
Timeline
- Start
- 2013-05
- Primary completion
- 2014-02
- Completion
- 2014-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | gevokizumab | Monoclonal antibody | — | Subcutaneous |